Long-term outcomes of the Mosaic mitral valve in patients under 65
Official title: Long Term Patient Outcomes and Product Durability of the Mosaic Mitral Valve Bioprosthesis in Patients Under 65
Run by ProMedica Health System · NCT06917586 · Data updated 2026-11-12
This study looks at how well the Mosaic mitral valve works over time in people under 65 who have had valve replacement surgery.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | ProMedica Health System Academic / other |
| Locations | 1 site (Toledo, Ohio) |
| Status | Recruiting |
| Started | January 1, 2025 |
| Main results expected | July 1, 2026 |
| Study ends | July 1, 2027 |
| Registry record updated | February 20, 2026 |
| Trial ID | NCT06917586 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients under 65 years old who have received the Mosaic mitral valve bioprosthetic at ProMedica Toledo Hospital.
✕Probably not a fit
Patients over the age of 65 or those who had their surgery performed at institutions other than ProMedica Toledo Hospital may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study evaluates the long-term efficacy and stability of the Mosaic bioprosthetic mitral valve in patients under the age of 65 who have undergone valve replacement at ProMedica Toledo Hospital. It aims to assess patient outcomes, including the incidence of structural valve deterioration and overall performance of the valve. The study addresses a gap in existing literature regarding younger patients, as most research has focused on older populations. By analyzing these outcomes, the study seeks to provide valuable insights into the durability and effectiveness of this specific valve type in a younger demographic.
Why it matters
Potential benefit: If successful, this study could provide critical information on the long-term performance of the Mosaic mitral valve, potentially improving treatment decisions for younger patients with valve disease.
How similar studies have gone: While studies have documented the efficacy of bioprosthetic valves in older populations, this specific focus on younger patients with the Mosaic mitral valve is relatively novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Received the Mosaic Mitral Valve Bioprosthetic at ProMedica Toledo Hospital * Under the age of 65 Exclusion Criteria: * Over the age of 65 * Under the age of 18 * Surgery performed at institutions outside of ProMedica Toledo Hospital
Where it's running
-
ProMedica Toledo Hospital
Toledo, Ohio, United States Recruiting
Study contacts
- Principal investigator: Michael Moront, MD — ProMedica Health System
- Study coordinator: Dawn Muskiewicz, MS
- Email: dawn.muskiewicz@promedica.org
- Phone: 419-291-7517
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Nonintubated anesthesia for adults undergoing cardiac surgery with bypass
This trial tests a nonintubated airway approach with the goal of seeing if avoiding endotracheal intubation during elective valve or bypass surgery can reduce lung problems and help patients recover faster.
-
HemoCept device data collection during diagnostic right heart catheterization
This pilot will collect HemoCept device readings from adults having diagnostic right heart catheterization to see how the device records heart pressures.
-
Valvular Heart Disease Registry Focusing on Gender Differences
This registry will track care and outcomes for adults with valvular heart disease to see if there are gender differences from hospital admission through the first outpatient follow-up.
-
Asia‑Pacific registry of mitral and tricuspid valve‑in‑valve and valve‑in‑ring procedures
Collecting medical data from adults across the Asia‑Pacific who have had—or plan to have—mitral or tricuspid valve‑in‑valve or valve‑in‑ring procedures with a balloon‑expandable valve to see how patients do.
-
Using a chest tube to reduce heart rhythm issues after heart surgery
This study is testing if using a special chest tube after heart surgery can help reduce the chances of patients developing heart rhythm problems like atrial fibrillation.
-
Transplanting heart valves from donors into patients who need them
This study is testing if heart valves from donors can help kids and young adults who need valve replacements by providing a solution that grows with them and reduces the need for more surgeries later on.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.